Bambi Ntumba¹*, Mulamba Ngalula³, Mbaya Mutombo¹, Miandabu Mbiya¹, Kalenda Kabambi², Mbuyi Kanyinda² and Jean Ciceron Mbunda⁴

¹Mbujimayi Higher Institute of Arts and Crafts (ISAM) in the Democratic Republic of the Congo, Democratic Republic of the Congo
²Tshilenge Higher Institute of Medical Techniques in the Democratic Republic of the Congo, Democratic Republic of the Congo
³Faculty of Medicine and Public Health, Official University of Mbujimayi, Democratic Republic of the Congo
⁴Epidemiological Surveillance Analyst, Provincial Health Division, Eastern Kasai, Democratic Republic of the Congo

*Corresponding Author: Bambi Ntumba, Mbujimayi Higher Institute of Arts and Crafts (ISAM) in the Democratic Republic of the Congo, Democratic Republic of the Congo.

Received: June 07, 2021; Published: July 08, 2021

Abstract

Introduction: Diabetes is a major cause of morbidity and mortality. It is therefore a costly disease for the patient, families and society. The goal is to study the epidemiological and clinical aspects, to report the factors causing decompensation and the evolutionary modalities with a view to improving care in Mbujimayi (DRC).

Materials and Methods : This study was prospective in nature, lasting from January 01, 2020 to December 31, 2020. It was carried out at the Dipumba General Referral Hospital. Covering 310 diabetic patients, 79 of whom had developed ketoacidosis either a frequency of 25.5% in whom the basic sociodemographic and epidemiological variables were studied. The data collected was encoded on an Excel software table (Microsoft 2007) then imported for processing on Epi Info software version 6.O and the test processing was done on professional Word XP software, the test used is Kh2 with P < 0.05.

Results: The frequency of diabetic ketoacidosis was 25.5% of cases in the Internal Medicine department. For all of our patients, ketoacidosis is predominant in people under 40 years of age. Ketoacidosis occurs in any diabetic patient, the average age of our patients was 42.3 Plus or minus 3.6 years with the target age range between 56-70 years, the male sex was more concerned with 54, 4℅ against 45, 6℅ for the female sex, the clinic of which can be superimposed on that described by the literature. Infections ranked first as a trigger in our study with 64.6℅ and followed by discontinuation of treatment 13.9℅. The course is marked by a mortality of 25 cases or 31.64℅.

Conclusion: Ketoacidosis remains a therapeutic emergency that requires careful management, especially in the acute phase. The infections revealed ketoacidosis in the majority of our patients.

Keywords: Ketoacidosis; Diabetes ; Mortality

References

1. Boutabia WA. “Diabetic ketoacidosis in children from the Annaba CHU”. Pediatric Archives5 (2008): 950-951.
2. Chauhan SP., et al. “Diabetic ketoacidosis catting pregnancy”. Journal of Perinatology 16 (1996): 173-175.
3. Djorolo F., et al. “Evolution of the hospital prevalence of diabetes mellitus in an African environment: a retrospective study in the internal medicine department at the national hospital and university center of Cotonou”. Benin Medical (2006): 33.
4. FID (International Diabetes Federation African region): guide for the management of type 2 diabetes for sub-Saharan Africa.
5. Guindo Issa. “Hypertension in type 2 diabetic patients followed at the reference health center in commune I of the district of Bamako”. Thesis of Medicine.
6. Kambola P., et al. “Diabetic ketoacidosis in adults at Sendwe hospital in Lubumbashi: about 51 cases”. Pan African Medical Journal 13 (2014): 324.
7. Kandjingu K. “Diabetes in the Democratic Republic of Congo”. Congo Medicine (2006): 626-627.
8. Lawrence S., et al. “Population-based study of incidence and risk factors for oedma in pediatric ketoacidosis”. Journal of Pediatrics 146 (2005): 688-692.
9. Lokrou A and Zohou G. Diabetic ketoacidosis in Côte d'Ivoire. “Study of a homogeneous female population at the Treichville University Hospital. Proposal of a therapeutic strategy adapted to Africa”. French Review of Clinical Endocrinology, Nutrition and Metabolism6 (1995): 571-589.
10. Lokrou A and Kouassi F. “Review of 9 years of management of ketoacidosis in adult African diabetes in Côte-d'Ivoire”. Medicine of Metabolic Diseases3 (2014): 330-334.
11. Monabeka HG and Mbika CH. “Ketoacidosis in children and teenagers in congo”. Health3 (2003): 139-141.
12. Newton CA and Raskin P. “Diabetic ketoacidosis in type 1 and type 2 diabetes mellitus: clinical and biochemical difference”. Archives of Internal Medicine17 (2004): 1925-1931.
13. Orban JC and Ichai C. “Metabolic complications of diabetes. Elsevier Masson SAS”. Resuscitation 17 (2008): 761-767.
14. Otmane DK. “Therapeutic evolution of the diabetic patient: practice and educational messages”. Thesis of the Faculty of Medicine and Pharmacy of Fez. 129/123 (2012): 185.
15. Pichard E., et al. “Diabetic ketoacidosis in Mali concerning 20 cases”. Annales de la Société royale zoologique de Belgique 68 (2002): 67-72.
16. Pouye A., et al. “Diabetic ketoacidosis in an internal medicine department”. Dakar Medical 48 (2003): 108-111.
17. Pr Grimaldi A. “Diabetology: diabetic ketoacidosis: pathophysiology, etiology, diagnosis, treatment”. 78.
18. Sarr A., et al. “Ketoacidosis in type 1 diabetic subjects concerning 73 cases collected in Dakar”. Mali Medical4 (2011): 50-54.
19. Tenoutasse S., et al. “Diabetic ketoacidosis: diagnosis, management, prevention”. Revue Médicale de Bruxelles 31 (2010): 71-76.
20. Usher-Smith JA., et al. “Variation between countries the frequency of diabetic ketoacidosis at first presentation of type 1 diabetes inchildreen: a systematic review”. Diabetologia 55 (2012): 2878-2894.
21. Yan H., et al. “The occurrence of diabetic ketoacidosis in adults”. International Medicine1 (2000): 10-14.

Citation

Citation: Bambi Ntumba., et al. “Diabetic Acidoketosis in the Democratic Republic of Congo: Clinical Epidemic Approach (79 Colliged Cases)”.Acta Scientific Medical Sciences 5.8 (2021): 03-09.

Copyright

Copyright: © 2021 Bambi Ntumba., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.